September 22, 2022
HKU Vice-Chancellor visits CTSCB
Professor Xiang ZHANG, Vice-Chancellor of The University of Hong Kong, sends his full support to InnoHK Centres by visiting CTSCB and others
September 22nd, 2022 - Professor Xiang Zhang, the Vice-Chancellor of The University of Hong Kong (HKU), visited Centre for Translational Stem Cell Biology (CTSCB) and met with the fellow young scientists. During the visit, Professor Pengtao Liu CTSCB’s Managing Director, alongside with Professor Chak-Sing Lau, the Dean of Medicine at the HKU and CTSCB Programme leader, showcased the translational research plans on Expanded Potential Stem Cells (EPSCs) to Professor Zhang.
From Left to Right: Dr. Guocheng LAN (Principal Researcher, CTSCB), Professor Anderson SHUM (Managing Director, ABIC), Professor Chak-Sing LAU (Dean of Faculty of Medicine, HKU & Programme Leader, CTSCB), Professor Xiang ZHANG (Vice-Chancellor, HKU), Professor Pengtao LIU (Managing Director, CTSCB), Professor Fang LIU (Senior Scientific Director, CTSCB), Ms Sara LO (Acting Chief Operation Officer, HKU Innovation Holdings)
Professor Liu briefing about EPSC works in CTSCB laboratory
Presenting translational ideas in CTSCB Meeting Room
September 19, 2022
CTSCB showcases in RTHK I&T Programme
RTHK invites CTSCB to showcase in a 3-min TV programme, "I&T New Era 創科新里程"
September 19th, 2022 – Centre for Translational Stem Cell Biology (CTSCB) is[DRL1] [MK2] invited to showcase in a 3-min TV programme produced by Radio Television Hong Kong (RTHK – 香港電台), “I&T New Era 創科新里程”.
While CTSCB’s Managing Director Professor Pengtao Liu and Principal Investigator, Dr. Sau-Fong Vera Chan,were interviewed, a group of CTSCB researchers also participated in the video-shooting by conducting experiments with their unique skillsets.
Dr. Chang MING, CTSCB Post-Doctoral Fellow, working on Neon Transfection System
Dr. Vera CHAN talking about CTSCB’s strategies in Regenerative Medicine
Professor Pengtao LIU introducing Expanded Potential Stem Cells (EPSCs)
August 31st, 2022 – A group of four students has completed their Summer Internship programme in Centre for Translational Stem Cell Biology (CTSCB). Miss Ri Min TAN, a Year 4 undergraduate from HKU Faculty of Education, was invited to summarise her experience upon completion of this internship.
According to her, one thing she has learnt was to pay extra attention on experiments and apply that on planning, the internship has also allowed her to identify her own strengths and weaknesses. “I am grateful for the opportunity given. I believe all the skills learnt in CTSCB have better prepared me for my future research career,” says Ri Min. She decides to continue her research work in CTSCB as a Research Assistant.
From Left to Right: Shao XU (Research Assistant), Ri Min TAN (Summer Intern), Tracy LEUNG (Summer Intern), Prof. Fang LIU (Senior Scientific Director, Prof. Pengtao LIU (Managing Director)
"Having all supportive colleagues working together allowed me to adjust to a new and fast-paced working environment
August 3, 2022
Shanghai Pharmaceuticals Visit
Shanghai Pharmaceuticals is looking for business collaborations in Hong Kong, where CTSCB is invited to present stem cell translational ideas for potential investment
August 3rd, 2022 – Shanghai Pharmaceuticals arranged a visit to Hong Kong Science and Technology Park seeking for business collaboration with InnoHK centres. Centre for Translational Stem Cell Biology (CTSCB) was honorably chosen to be one of the presenters on the day to pitch our business to the senior management at Shanghai Pharmaceuticals.
The leaders expressed great interest on CTSCB’s research projects and gave multiple constructive feedback and professional advice to the potential business development. CTSCB will anticipate cooperation with Shanghai Pharmaceuticals to promote biomedical and healthcare development in Hong Kong.
Professor Fang LIU, CTSCB Senior Scientific Director, presenting potential EPSCs technology development to senior management of Shanghai Pharmaceuticals
Group Photo with senior management members of CTSCB and Shanghai Pharmaceuticals
June 23, 2022
HKUSU Biological Sciences Society Visits for Industrial Insight
The HKUSU Society gains a brief industrial insight and experimental experience in stem cell biology, anticipates to explore further in such field
June 23rd, 2022 – A group of 20 undergraduate students ranging from Year 1 to Year 4, from Biological Sciences Society from the HKU Student Union, visited Centre for Translational Stem Cell Biology (CTSCB) for a half-day excursion for an opportunity to gain valuable industry exposure and learn all about stem cell biology. While Prof. Fang LIU, the CTSCB Senior Scientific Director, gave a briefing, Prof. Pengtao Liu, CTSCB Managing Director, also expressed his warmest welcome to all future young scientists.
Students participated in three arranged experiments, and they are thrilled to have the opportunity to operate actual experimental tools as the wet lab practical courses at the HKU have been suspended due to the pandemic.
Based on the experience, CTSBC are informed that most of the students are interested to work as an intern, we welcome applications starting from next March annually.
HKUSU Biological Sciences Society taking group photo in front of CTSCB
Ms Yuqing ZHAI, CTSCB Research Assistant, Demonstrating the operation of pipette
Dr. Xueyan LIU, CTSCB Post-Doctoral Fellow, explaining how to correctly use a microscope to view the stem cell
What one of China’s most prestigious medical research centres’ arrival in Hong Kong could do for local innovation
Local scientists say arrival of the Guangzhou Institutes of Biomedicine and Health at city’s Science Park will bring much-needed staff and funding for vital stem cell research.
Rm1105, 11/F, 17W, HKSTP, Shatin, N.T., Hong Kong
Copyright ©2022 All rights reserved | by Centre for Translational Stem Cell Biology